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(57) ABSTRACT 
The present invention provides a method for producing an 
anterior cruciate ligament ex vivo. The method comprises 
seeding pluripotent stem cells in a three dimensional matrix, 
anchoring the seeded matrix by attachment to two anchors, 
and culturing the cells within the matrix under conditions 
appropriate for cell growth and regeneration, while subject- 
ing the matrix to one or more mechanical forces via move- 
ment of one or both of the attached anchors. Bone marrow 
stromal cells are preferably used as the pluripotent cells in 
the method. Suitable matrix materials are materials to which 
cells can adhere, such as a gel made from collagen type I. 
Suitable anchor materials are materials to which the matrix 
can attach, such as Goinopra coral and also demineralized 
bone. Optimally, the mechanical forces to which the matrix 
is subjected mimic mechanical stimuli experienced by an 
anterior cruciate ligament in vivo. This is accomplished by 
delivering the appropriate combination of tension, 
compression, torsion, and shear, to the matrix. The bioengi- 
neered ligament which is produced by this method is char- 
acterized by a cellular orientation and/or matrix crimp 
pattern in the direction of the applied mechanical forces, and 
also by the production of collagen type I, collagen type 111, 
and fibronectin proteins along the axis of mechanical load 
produced by the mechanical forces. Optimally, the ligament 
produced has fiber bundles which are arranged into a helical 
organization. The method for producing an anterior cruciate 
ligament can be adapted to produce a wide range of tissue 
types ex vivo by adapting the anchor size and attachment 
sites to reflect the size of the specific type of tissue to be 
produced, and also adapting the specific combination of 
forces applied, to mimic the mechanical stimuli experienced 
in vivo by the specific type of tissue to be produced. The 
methods of the present invention can be further modified to 
incorporate other stimuli experienced in vivo by the par- 
ticular developing tissue, some examples of the stimuli 
being chemical stimuli, and electro-magnetic stimuli. Some 
examples of tissue which can be produced include other 
ligaments in the body (hand, wrist, elbow, knee), tendon, 
cartilage, bone, muscle, and blood vessels. 
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BIOENGINEERED ANTERIOR CRUCIATE 
LIGAMENT 
GOVERNMENT SUPPORT 
This invention was made with government support under 
Grant Nos. NCC8-174 and NAG9-836 awarded by the 
NASA. The government has certain rights in the invention. 
BACKGROUND OF THE INVENTION 
Every year more than 135,000 Americans tear or rupture 
their anterior cruciate ligament (ACL) (Chen et al., J .  
Biomed. Mat. Res. 14: 567-586 (1980); Butler, D. L., J .  
Orthop. Res. 7: 91Ck921 (1989); Langer et al., Science 260: 
92Ck926 (1993)). The ACL serves as a primary stabilizer of 
anterior tibial translation and as a secondary stabilizer of 
valgus-varus knee angulation, and is often susceptible to 
rupture or tear resulting from a flexion-rotation-valgus force 
associated with sports injuries and traffic accidents. Rup- 
tures or tears often result in severe limitations in mobility, 
pain and discomfort, and the loss of an ability to participate 
in sports and exercise. Failures of the ACL are classified in 
three categories: (1) ligamentous (ligament fibers pull apart 
due to tensile stress), (2) failure at the bone-ligament inter- 
face without bone fracture, and (3) failure at the bone- 
ligament interface with bone fracture at the attachment site 
of bone and ligament. The most common type of ACL 
failure is the first category, ligamentous. 
Total surgical replacement and reconstruction are required 
when injury to the ACL involves significant tear or rupture. 
Four options have been utilized for repair or replacement of 
a damaged ACL: (1) autografts, (2) allografts, (3) 
xenografts, and (4) synthetic prostheses (degradable and 
non-degradable). To date, no surgical repair procedure has 
been shown to restore knee function completely, and novel 
treatment options would likely benefit a large number of 
patients. 
The problems associated with the use of synthetic ACL 
replacements, along with the limited availability of the 
donor tissue, have motivated research towards the develop- 
ment of functional and biocompatible equivalents of native 
tissues. This shift from synthetic to biologically-based ACL 
replacements first applied in early studies in which collag- 
enous ACL prostheses were prepared as composite struc- 
tures consisting of reconstituted type I collagen fibers in a 
collagen I matrix with polymethylmethacrylate bone fixa- 
tion plugs, and used as anterior cruciate ligament replace- 
ment tissues in rabbits (Dum et al., Am. J.  Sports Medicine 
20: 507-515 (1992)). Subsequent studies incorporated 
active biological components into the process, such as 
ligament fibroblasts seeded on cross-linked collagen fiber 
scaffolds that were used as ligament analogs (Dum et al., J .  
Biomedical Materials Res. 29: 1363-1371 (1995); Dum, M. 
G., Materials Res. SOC. Bulletin, Nov: 43-46 (1996)), and 
suggested that structures approximating native ligaments 
can be generated. A tendon gap model, based on pre-stressed 
collagen sutures seeded with mesenchymal stem cells pro- 
vided improved repair of large tendon defects (Young et al., 
1998). Goulet et al. modified the collagen-fibroblast system 
by using ligament fibroblasts in non-cross-linked collagen, 
with bone anchors to pre-stress the tissue and facilitate 
surgical implantation (Goulet et al., Tendons and Ligaments. 
In Principles of Tissue Engineering, Ed. R. Lanza, R. 
Langer, W. Chick. R. G. Landes Co. pp 633-643, R. G. Lanz 
Co. and Academic Press, Inc., San Diego, Calif. (1997)). 
Passive tension produced by growing the new ligament in a 
vertical position induced fibroblast elongation and the align- 
ment of the cells and surrounding extracellular matrix. 
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However, to date, no human clinical trials have been 
reported with tissue culture bioengineered anterior cruciate 
ligaments. This is due to the fact that each approach has 
failed to address one or more of the following issues: (1) the 
s lack of a readily available cell or tissue source, (2) the 
unique structure (e.g. crimp pattern, peripheral helical pat- 
tern and isometric fiber organization) of an ACL, and (3) the 
necessary remodeling time in vivo for progenitor cells to 
differentiate and/or autologous cells to infiltrate the graft, 
i o  thus extending the time a patient must incur a destabilized 
knee and rehabilitation. The development of methods for 
generating more fully functional bioengineered anterior cru- 
ciate ligaments would greatly benefit the specific field of 
knee reconstructive surgery, and would also provide wider 
is benefits to the overall field of in vitro tissue generation and 
replacement surgery. 
SUMMARY OF THE INVENTION 
The present invention provides a method for producing an 
2o anterior cruciate ligament ex vivo. The method comprises 
seeding pluripotent stem cells in a three dimensional matrix, 
anchoring the seeded matrix by attachment to two anchors, 
and culturing the cells within the matrix under conditions 
appropriate for cell growth and regeneration, while subject- 
ing the matrix to one or more mechanical forces via move- 
ment of one or both of the attached anchors. In a preferred 
embodiment, the pluripotent cells are bone marrow stromal 
cells. Suitable matrix materials are materials to which cells 
can adhere. A preferred matrix material is collagen type I 
30 gel. Suitable anchor materials are materials to which the 
matrix can attach. Preferred anchor material includes Goi- 
nopra coral which has been treated to convert the calcium 
carbonate to calcium phosphate, and also demineralized 
bone. In a preferred embodiment, the mechanical forces to 
3s which the matrix is subjected mimic mechanical stimuli 
experienced by an anterior cruciate ligament in vivo. This is 
accomplished by delivering the appropriate combination of 
tension, compression, torsion, and shear, to the matrix. 
Another aspect of the present invention is the bioengi- 
neered ligament which is produced by the above method. 
The ligament is characterized by a cellular orientation and/or 
matrix crimp pattern in the direction of the applied mechani- 
cal forces, and also by the production of collagen type I, 
4s collagen type 111, and fibronectin proteins along the axis of 
mechanical load produced by the mechanical forces. In a 
preferred embodiment, the ligament is characterized by the 
presence of fiber bundles which are arranged into a helical 
organization. 
Another aspect of the present invention is a method for 
producing a wide range of ligament types ex vivo using an 
adaptation of the method for producing an anterior cruciate 
ligament by adapting the anchor size to reflect the size of the 
specific type of ligament to be produced, and also adapting 
5s the specific combination of forces applied, to mimic the 
mechanical stimuli experienced in vivo by the specific type 
of ligament to be produced. Similar adaptations of the 
method can be made to produce other tissues ex vivo from 
pluripotent stem cells, by adapting the mechanical forces 
60 applied during cell culture to mimic stresses experienced in 
vivo by the specific tissue type to be produced. The methods 
of the present invention can be further modified to incorpo- 
rate other stimuli experienced in vivo by the particular 
developing tissue, some examples of the stimuli being 
Another aspect of the present invention relates to the 
specific tissues which are produced by the methods of the 
2s . 
4o 
50 
65 chemical stimuli, and electromagnetic stimuli. 
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present invention. Some examples of tissue which can be 
produced include other ligaments in the body (hand, wrist, 
elbow, knee), cartilage, bone, tendon, muscle, and blood 
vessels. 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. 1 is a picture of bioreactor tubes containing growing 
ligaments. 
FIG. 2 is a schematic of the mechanical apparatus with an 
attached bioreactor tube. 
FIG. 3 is a picture of an actual mechanical apparatus with 
attached reactor tubes containing growing ligaments. 
FIG. 4 is a diagrammatic representation of the rotational 
strain rates and the translational strain rates experienced by 
the growing ligaments in Experiment 2. 
FIGS. 5 contains diagrammatic representations of the 
mechanical regime applied to the growing ligaments in 
Experiment 3. u) Indicates the rotational and translational 
strain rates as a % of strain over time (min). b) Indicates 
rotational and linear deformation experienced over the 
course of time. 
FIGS. 6 graphically illustrates the cell density data 
obtained from Experiment 3. u)  Legend; b) Schematic 
diagram representing the cross sectional areas from which 
cell density measurements were taken; c) Data graphically 
representing the average of 8 individual cell density mea- 
surements taken from peripheral and central regions of a 
cross sectional area of a mechanically stimulated and a 
statically grown ligament. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The present invention is based on the finding that the 
histomorphological properties of an in vitro produced 
bioengineered tissue generated from pluripotent cells within 
a matrix are affected by the direct application of mechanical 
force to the matrix during tissue generation. This discovery 
provides important new insights into the relationship 
between mechanical stress, biochemical and cell immobili- 
zation methods, and cell differentiation, and has applications 
in producing a wide variety of tissues in vitro from pluri- 
potent cells. 
One aspect of the present invention relates to a method for 
producing an anterior cruciate ligament (ACL) ex vivo. 
Cells capable of differentiating into ligament cells are grown 
under conditions which simulate the movements and forces 
experienced by an ACL in vivo through the course of 
embryonic development into mature ligament function. This 
is accomplished by the following steps: Under sterile 
conditions, pluripotent cells are seeded within a three 
dimensional matrix, of cylindrical shape, which is com- 
prised of a material to which the cells can adhere (e.g. 
collagen gel). The faces of the matrix cylinder are each 
attached to respective anchors, through which a range of 
forces are to be applied to the matrix. To facilitate force 
delivery to the matrix, it is preferable that the entire surface 
of each respective face of the matrix contact the face of the 
respective anchors. Anchors with a shape which reflects the 
site of attachment (e.g. cylindrical) are best suited for use in 
this method. Once assembled, the cells in the anchored 
matrix are cultured under conditions appropriate for cell 
growth and regeneration. The matrix is subjected to one or 
more mechanical forces applied through the attached 
anchors (e.g. via movement of one or both of the attached 
anchors) during the course of culture. 
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In the experiments described in the Exemplification sec- 
tion below, the applied mechanical stimulation was shown to 
dramatically influence the morphology, and cellular organi- 
zation of the progenitor cells within the resulting tissue. The 
extracellular matrix components secreted by the cells and 
organization of the extra cellular matrix throughout the 
tissue was also significantly influenced by the forces applied 
to the matrix during tissue generation. During in vitro tissue 
generation the cells and extra cellular matrix aligned along 
the axis of load, reflecting the in vivo organization of a 
native ACL which is also along the various load axes 
produced from natural knee joint movement and function. 
These results suggest that the physical stimuli experienced 
in nature by cells of developing tissue, such as the ACL, play 
a significant role in progenitor cell differentiation and tissue 
formation. They further indicate that this role can be effec- 
tively duplicated in vitro by mechanical manipulation to 
produce a similar tissue. The more closely the forces pro- 
duced by mechanical manipulation resemble the forces 
experienced by an ACL in vivo, the more closely the 
resultant tissue will resemble a native ACL. 
One or more types of pluripotent cells are used in the 
method. Such cells have the ability to differentiate into a 
wide variety of cell types in response to the proper differ- 
entiation signals. More specifically, the method requires 
cells which have the ability to differentiate into cells of 
ligament tissue. In a preferred embodiment, bone marrow 
stromal cells, also known as mesenchymal cells are used. If 
the resulting bioengineered ligament is to be transplanted 
into a patient, the cells should be derived from a source 
which is compatible with the intended recipient. The recipi- 
ent will generally be a human, although applications in 
veterinary medicine also exist. In one embodiment, the cells 
are obtained from the recipient, although compatible donor 
cells may also be used. The determination of compatibility 
is within the means of the skilled practitioner. 
The three dimensional matrix used in the method is 
potentially comprised of any material to which the cells can 
adhere. This matrix serves as a preliminary matrix, which is 
supplemented and possibly even replaced by extracellular 
matrix components produced by the differentiating cells. 
Use of a more specialized matrix may enhance or accelerate 
the development of the ACL. For instance, a matrix which 
has specific mechanical properties (e.g. increased tensile 
strength) can withstand strong forces prior to reinforcement 
from cellular extracellular matrix components. Other prop- 
erties which may also be useful in a preliminary matrix 
include, without limitation, biocompatibility and suscepti- 
bility to biodegradation. 
The matrix used in the examples disclosed herein was a 
collagen gel. One of skill in the art will recognize that the 
properties of the preliminary matrix can be modulated and 
enhanced by modifying the matrix components, and that use 
of an enhanced matrix is likely to increase the efficiency of 
production of a bioengineered ACL. Such modifications 
include, without limitation, modifications aimed at modu- 
lating the mechanical and mass transport properties of the 
matrix. In particular, the concentration of collagen and the 
degree of crosslinking of collagen in the matrix can signifi- 
cantly influence the mechanical properties of the matrix, as 
well as the diffusional transport rates of nutrients and large 
molecules. Since the ACL is made primarily of collagen type 
I, it is particularly well suited for use as a preliminary matrix 
component. The concentration of collagen type I in the 
matrix should be sufficient to support cell adhesion, prolif- 
eration and differentiation. In one embodiment, collagen 
type I is used at a final concentration from about 2 mgiml to 
US 6,287,340 B1 
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about 6 mgiml. In another embodiment the final concentra- culture process, the matrix is subjected to one or more 
tion of collagen type I in the matrix is about 2 mgiml. In mechanical forces via movement of one or both of the 
another embodiment, the collagen in the preliminary matrix attached anchors. The mechanical forces of tension, 
is crosslinked. Suitable processes for cross linking collagen compression, torsion and shear, and combinations thereof, 
include without limitation, dehydrothermal crosslinking and 5 are applied in the appropriate combinations, magnitudes, 
ultraviolet irradiation crosslinking. Other suitable matrix and frequencies to mimic the mechanical stimuli experi- 
materials include, without limitation polysaccharides, enced by an ACL in vivo. 
alginates, other proteins such as silk and elastin, synthetic Various factors will influence the amount of force which 
polymers such as polyglycolic acid and polylactic acid and can be tolerated by the matrix (e.g. matrix composition, cell 
copolymers of the two, and demineralized bone. density). Matrix strength is expected to change through the 
The cells are seeded within the preliminary matrix either course of tissue development. Therefore, mechanical forces 
pre- or post-matrix formation, depending upon the particular applied will increase or decrease in magnitude, duration, and 
matrix used and the method of matrix formation. Uniform variety over the period of ligament generation, to appropri- 
seeding is preferable. In theory, the number of cells seeded ately correspond to matrix strength at the time of applica- 
does not limit the final ligament produced, however optimal 15 tion. 
seeding may increase the rate of generation. optimal seeding 
amounts will depend on the specific culture conditions. In 
one embodiment, the matrix is seeded with from about 0.05 
to 5 times the physiological cell density of a native ligament. 
The more accurate the intensity and combination of 
stimuli applied to the matrix during tissue development, the 
more the resulting ligament will resemble a native ACL, 
TWO issues must be considered regarding the natural func- 
The seeded matrix is subjected to mechanical forces 2o tion of the ACL when devising the in vitro mechanical force 
which are applied through a set of attached anchors. Anchors regimen that closely mimics the in vivo environment, (1) the 
are defined herein as comprising a solid surface to which different types of motion experienced by the ACL and the 
force can be applied and transmitted to an attached matrix. responses of the ACL to knee joint movements and (2) the 
The anchors must be made of a material suitable for matrix extent of the mechanical stresses experienced by the liga- 
attachment, and the resulting attachment should be strong 25 ment. Specific combinations of mechanical stimuli are gen- 
enough to endure the stress of the mechanical forces applied. erated from the natural motions of the knee structure and 
The preliminary matrix must be able to attach to the anchors. transmitted to the native ACL. To briefly describe the 
In addition, it is preferable that the anchors be of a material motions of the knee, the connection of the tibia and femur 
which is suitable for the attachment of extracellular matrix by the ACL between provides six degrees of freedom when 
which is produced by the differentiating cells. Some 30 considering the motions of the two bones relative to each 
examples of suitable anchor material include, without other: the tibia can move in the three directions and can 
limitation, Goinopra coral and demineralized bone. In a rotate relative to the axes for each of these three directions. 
preferred embodiment, the anchors are Goinopra coral The knee is restricted from achieving the full ranges of these 
which has a pore size of 500 pM, and the coral is treated by six degrees of freedom due to the presence of ligaments and 
means to convert the calcium carbonate of the coral to 35 capular fibers and the knee surfaces themselves (Biden et al., 
calcium phosphate, prior to use. Experimental methods used to evaluate knee ligament func- 
Alternatively, anchor material may be created or further tion. In Knee Ligaments: Structure, Function, Injury and 
enhanced by infusing a selected material with a factor which Repair, Ed. D. Daniel et al. Raven Press, pp.135-151 
promotes matrix binding. The term infuse is considered to (1990)). Small translational movements are also possible. 
include any method of application which appropriately 40 The attachment sites of the ACL are responsible for its 
distributes the factor onto the anchor (e.g. coating, stabilizing roles in the knee joint. The ACL functions as a 
permeating, contacting). Examples of such factors include primary stabilizer of anterior-tibial translation, and as a 
without limitation, laminin, fibronectin, any extracellular secondary stabilizer of valgus-varus angulation, and tibial 
matrix protein that promotes adhesion, silk, factors which rotation (Shoemaker et al., The limits of knee motion. In 
contain arginine-glycine-aspartate peptide binding regions. 45 Knee Ligaments: Structure, Function, Injury and Repair, 
Growth factors or bone morphogenic protein can also be Ed. D. Daniel et al. Raven Press, pp.1534-161 (1990)). 
used to enhance anchor attachment. In addition, anchors Therefore, the ACL is responsible for stabilizing the knee in 
may be pre-seeded with cells (e.g. stem cells, ligament cells, three of the six possible degrees of freedom. As a result, the 
osteoblasts) which adhere to the anchors and bind the ACL has developed a specific fiber organization and overall 
matrix, to produce enhanced matrix attachment. so structure to perform these stabilizing functions. The present 
The matrix is attached to the anchors via contact to the invention simulates these conditions in vitro to produce a 
anchor face or alternatively by actual penetration of the tissue with similar structure and fiber organization. 
matrix material through the anchor material. Because the The extent of mechanical stresses experienced by the ACL 
force applied dictates the final ligament produced and the can be similarly summarized. The ACL undergoes cyclic 
force is applied through the anchors, the size of the final 55 loads of about 300 N between one and two million cycles per 
ligament produced is in part dictated by the size of the year. It is also critical to consider linear stiffness (-182 
attachment site of the anchor. One of skill in the art will Nimm), ultimate deformation (100% of ACL) and energy 
appreciate that an anchor of appropriate size to the desired absorbed at failure (12.8 N-m) (Woo et al., The tensile 
final ligament should be used. A preferred anchor shape for properties of human anterior cruciate ligament (ACL) and 
the formation of an ACL is a cylinder, however, one of skill 60 ACL graft tissues. In Knee Ligaments: Structure, Function, 
in the art will appreciate that other anchor shapes and sizes Injury and Repair, Ed. D. Daniel et al. Raven Press, 
will also function adequately. In a preferred embodiment, pp.279-289 (1990)) when developing an ACL surgical 
anchors have an appropriate size and composition for direct replacement. 
insertion into bone tunnels in the femur and tibia of a The Exemplification section below details the production 
recipient. 65 of a prototype bioengineered anterior cruciate ligament 
The cells are cultured within the matrix under conditions (ACL) ex vivo. Mechanical forces mimicking a subset of the 
appropriate for cell growth and differentiation. During the mechanical stimuli experienced by a native ACL in vivo 
US 6,287,340 B3 
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(rotational deformation and linear deformation) were above described methods. The bioengineered ligament pro- 
applied in combination, and the resulting ligament which duced by these methods is characterized by cellular orien- 
was formed was studied to determine the effects of the tation and/or a matrix crimp pattern in the direction of the 
applied forces on tissue development. Exposure of the mechanical forces applied during generation. The ligament 
developing ligament to physiological loading during in vitro 5 is also characterized by the productionipresence of extra 
formation induced the cells to adopt a defined orientation cellular matrix components (e.g. collagen type I, and type 
along the axes of load, and to generate extracellular matrices 111, elastin, and fibronectin proteins) along the axis of 
along the axes as well. These results indicate that the mechanical load experienced during culture. In a preferred 
incorporation of additional mechanical forces into the embodiment, the ligament fiber bundles are arranged into a 
regime to produce a more complex network of load axes that helical organization, as discussed above. 
more accurately mimics the environment of the native ACL, The above methods are not limited to the production of an 
will produce a bioengineered ligament which more closely ACL, but can also be used to produce other ligaments found 
resembles a native ACL. The different mechanical forces to in the knee (e.g. posterior cruciate ligament) or other parts 
be applied include, without limitation, tension, compression, of the body (e.g. hand, wrist, ankle, elbow and shoulder). All 
torsion, and shear. These forces are applied in combinations 1~ moveable joints in a human body have specialized ligaments 
which simulate forces experienced by an ACL in the course which connect the articular extremities of the bones in the 
of natural knee joint movements and function. These move- joint. Each ligament in the body has a specific structure and 
ments include, without limitation, knee joint extension and organization which is dictated by its function and environ- 
flexion as defined in the coronal and sagittal planes, and ment. The various ligaments of the body, their locations and 
knee joint flexion. Optimally, the combination of forces 2o functions are listed in Anatomy, Descriptive and Surgical 
applied mimics the mechanical stimuli experienced by an (Gray, H. , Eds. Pick, T. P., Howden, R., Bounty Books, New 
anterior cruciate ligament in vivo as accurately as is experi- York (1977)) the pertinent contents of which are incorpo- 
mentally possible. Varying the specific regimen of force rated herein by reference. By determining the physical 
application through the course of ligament generation is stimuli experienced by a given ligament, and incorporating 
expected to influence the rate and outcome of tissue 2s forces which mimic these stimuli, the above described 
development, with optimal conditions to be determined method for producing an ACL ex vivo can be adapted to 
empirically. Potential variables in the regimen include, with- produce a bioengineered ligament ex vivo which simulates 
out limitation: (1) strain rate, (2) repetition number, (3) any ligament in the body. 
duration at extreme points of ligament deformation, (4) force The specific type of ligament to be produced is predeter- 
levels, and (5) different force combinations. It will be 30 mined prior to ligament generation since several aspects of 
recognized by one of skill in the art that a potentially the method vary with the specific conditions experienced in 
unlimited number of variations exist. In a preferred embodi- vivo by the native ligament. The mechanical forces to which 
ment the regimen of mechanical forces applied produces the developing ligament is subjected during cell culture are 
helically organized fibers similar to those of the native determined for the particular ligament type being cultivated. 
ligament, described below. 35 The specific conditions can be determined by those skilled 
The fiber bundles of a native ligament are arranged into a in the art by studying the native ligament and its environ- 
helical organization. The mode of attachment and the need ment and function. One or more mechanical forces experi- 
for the knee joint to rotate -140" of flexion has resulted in enced by the ligament in vivo are applied to the matrix 
the native ACL inheriting a 90" twist and with the peripheral during culture of the cells in the matrix. The skilled practi- 
fiber bundles developing a helical organization. This unique 40 tioner will recognize that a ligament which is superior to 
biomechanical feature allows the ACL to sustain extremely those currently available can be produced by the application 
high loading. In the functional ACL, this helical organiza- of a subset of forces experienced by the native ligament. 
tion of fibers allows anterior-posterior and posterior-anterior However, optimally, the full range of in vivo forces will be 
fibers to remain relatively isometric in respect to one another applied to the matrix in the appropriate magnitudes and 
for all degrees of flexion, thus stabilizing the knee through- 45 combinations to produce a final product which most closely 
out all ranges of joint motion. In a preferred embodiment of resembles the native ligament. These forces include, without 
the invention, mechanical forces which simulate a combi- limitation, the forces described above for the production of 
nation of knee joint flexion and knee joint extension are an ACL. Because the mechanical forces applied vary with 
applied to the developing ligament to produce an engineered ligament type, and the final size of the ligament will be 
ACL which possesses this same helical organization. The 50 influenced by the anchors used, optimal anchor composition, 
mechanical apparatus used in the experiments presented in size and matrix attachment sites are to be determined for 
the Exemplification below provides control over strain and each type of ligament by the skilled practitioner. 
strain rates (both translational and rotational). An improved Another aspect of the present invention relates to the 
mechanical apparatus will monitor the actual load experi- production of other tissue types ex vivo using methods 
enced by the growing ligaments, serving to 'teach' the ss similar to those described above for the generation of 
ligaments over time through monitoring and increasing the ligaments ex vivo. The above described methods can also be 
loading regimes. Such a reactor can be designed by starting applied to produce a range of engineered tissue products 
from the features of the first generation bioreactor used in which involve mechanical deformation as a major part of 
the Experiments described in the Exemplification section their function, such as tendon, muscle (e.g. smooth muscle, 
below. TO these features (e.& ports for medium and gas 60 skeletal muscle, cardiac muscle), bone, cartilage, vertebral 
exchange, sterilizable) will be added features, including e.g. discs, and some types of blood vessels. Bone marrow stomal 
a flexibility to run multiple mechanical deformation pro- cells possess the ability to differentiate into these as well as 
grams concurrently. Such a system should have a precise other tissues. The results present in the Exemplification 
(strain-gauge) control of the applied forces, and an on-line section below indicate that growth in an environment which 
monitoring and control of mechanical loading parameters. 65 mimics the specific mechanical environment of a given 
Another aspect of the present invention relates to the tissue type will induce the appropriate cell differentiation to 
bioengineered anterior cruciate ligament produced by the produce a bioengineered tissue which significantly 
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resembles native tissue. The ranges and types of mechanical 
deformation of the matrix can be extended to produce a wide 
range of tissue structural organization. Preferably, the cell 
culture environment reflects the in vivo environment expe- 
rienced by the native tissue and the cells it contains, through- 
out the course of embryonic development to mature function 
of the cells within the native tissue, as accurately as possible. 
Factors to consider when designing specific culture condi- 
tions to produce a given tissue include, without limitation, 
the matrix composition, the method of cell immobilization, 
the anchoring method, the specific forces applied, and the 
cell culture medium. The specific regimen of mechanical 
stimulation depends upon the tissue type to be produced, and 
is established by varying the application of mechanical 
forces (e.g. tension only, torsion only, combination of ten- 
sion and torsion, with and without shear, etc.), the force 
amplitude (e.g. angle or elongation), the frequency and 
duration of the application, and the duration of the periods 
of stimulation and rest. 
The method for producing the specific tissue type ex vivo 
is an adaptation of the above described method for produc- 
ing an ACL. Components involved include pluripotent cells, 
a three dimensional matrix to which cells can adhere, and a 
plurality of anchors which have a face suitable for matrix 
attachment. The pluripotent cells (preferably bone marrow 
stroma cells) are seeded in the three dimensional matrix by 
means to uniformly immobilize the cells within the matrix. 
As discussed above, the only requirement for the matrix is 
that it be of a substance, or contain a substance, to which the 
cells can adhere, although certain matrix compositions will 
most likely prove optimal for specific tissues. Matrix shape 
is not viewed as a limiting factor to the method, however, a 
specific shape which resembles the final desired product 
may facilitate generation of the tissue. The number of cells 
seeded is also not viewed as limiting, however, seeding the 
matrix with a high density of cells may accelerate tissue 
generation. 
Once seeded, the matrix is attached to a plurality of 
anchors. The number of anchors, as well as their shape, and 
the shape and size of their sites of attachment to the matrix, 
depends upon the particular tissue being produced, and will 
reflect the nature of the forces applied to the matrix. For 
some tissues (e.g. cartilage, bone, vertebral discs), use of a 
solid matrix (e.g. demineralized bone or Goinopra coral) 
will be optimal. Because mechanical forces can be applied 
directly to a solid matrix, solid matrices may be considered 
herein to possess inherent anchors. If deemed necessary, the 
location and size of these inherent anchors is determined by 
the position and area of the solid matrix to which the 
mechanical force is applied. 
The specific forces applied are to be determined for each 
tissue type produced through examination of native tissue 
and the mechanical stimuli experienced in vivo. A given 
tissue type experiences characteristic forces which are dic- 
tated by location and function of the tissue within the body. 
For instance, cartilage is known to experience a combination 
of shear and compressionitension in vivo, bone experiences 
compression. Determination of the specific mechanical 
stimuli experienced in vivo by a given tissue is within the 
means of one of skill in the art. 
Additional stimuli (e.g. chemical stimuli, electromagnetic 
stimuli) can also be incorporated into the above described 
methods for producing bioengineered ligaments and other 
tissues. Cell differentiation is known to be influenced by 
chemical stimuli from the environment, often produced by 
surrounding cells, such as secreted factors, cell-cell contact, 
chemical gradients, and specific pH levels, to name a few. 
10 
Other more unique stimuli are experienced by more special- 
ized types of tissues (e.g. the electrical stimulation of cardiac 
muscle). The application of such tissue specific stimuli in 
concert with the appropriate mechanical forces is expected 
s to facilitate differentiation of the cells into a tissue which 
more closely approximates the specific natural tissue. 
Tissues produced by the above described methods provide 
an unlimited pool of tissue equivalents for surgical implan- 
tation into a compatible recipient. Engineered tissues may 
IO also be utilized for in vitro studies of normal or pathological 
tissue function, e.g. for in vitro testing of cell- and tissue- 
level responses to molecular, mechanical, or genetic 
manipulations. For example, tissues based on normal or 
transfected cells can be used to assess tissue responses to 
1s biochemical or mechanical stimuli, identify the functions of 
specific genes or gene products that can be either over- 
expressed or knocked-out, or to study the effects of phar- 
macological agents. Such studies will likely provide more 
insight into ligament development, normal and pathological 
20 function, and eventually lead toward fully functional tissue 
engineered replacements, based in part on already estab- 
lished tissue engineering approaches, new insights into cell 
differentiation and tissue development, and the use of 
mechanical regulatory signals in conjunction with cell- 
2s derived and exogenous biochemical factors to improve 
structural and functional tissue properties. 
The production of engineered tissues such as ligaments 
has the potential for applications such as harvesting bone 
marrow stoma cells from individuals at high risk for tissue 
30 injury (e.g. ACL rupture) prior to injury. These cells could 
be either stored until needed or seeded into the appropriate 
matrix and cultured and differentiated in vitro under 
mechanical stimuli to produce a variety of bioengineered 
prosthetic tissues to be held in reserve until needed by the 
35 donor. The use of bioengineered living tissue prosthetics that 
better match the biological environment in vivo, provide the 
required physiological loading to sustain for example, the 
dynamic equilibrium of a normal, fully functional ligament, 
should reduce rehabilitation time for a recipient of a pros- 
40 thesis from months to weeks, particularly if the tissue is 
pre-grown and stored. Benefits include a more rapid regain 
of functional activity, shorter hospital stays, and fewer 
problems with tissue rejections and failures. 
Exemplification 
The feasibility of using directly applied forces during 
tissue cultivation to promote in vitro formation of ACL-like 
structures was tested. A three-dimensional tissue culture 
system was developed utilizing precursor cells, obtained 
50 from bone marrow stroma, immobilized in a collagen gel 
matrix. The matrix was positioned within a bioreactor that 
subjected the matrix to defined types, magnitudes and fre- 
quencies of mechanical forces, corresponding in part to 
those experienced by an ACL during physiological loading 
5s in vivo. Cells within the matrix were cultured under condi- 
tions appropriate for proliferation during exposure of the 
matrix to the various mechanical forces, to produce a 
bioengineered anterior cruciate ligament ex vivo. Control 
tissues were cultured with no mechanical stimulation of the 
60 matrix under otherwise identical conditions. 
A bioreactor that would provide a reasonable range of 
mechanical options for deformation of the growing liga- 
ments was constructed. The reactor provided tensile/ 
compressive and torsional loads along the longitudinal axis 
65 and could accommodate up to 12 individual reactor tubes for 
the growth of ligaments. Although this reactor did not 
subject the growing ligament to the full range of deforma- 
4s 
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tions experienced in vivo, the information obtained from 
these preliminary experiments can be used to design a more 
advanced reactor. 
(l) the 
bioreactor tubes which provide the growth environment and 
attachment sites for the growing ligaments (shown in FIG. 
l), and (2) the mechanical apparatus to provide mechanical 
Histology was performed on the resulting tissue to exam- 
ine cell morphology. Ligament tissue samples were stained 
with hemotoxylin and eosin and visualized by light micros- 
copy at 400x. Results indicated that approximately 50% of 
the cells from the mechanically stimulated ligaments exhib- 
lted avid morpho~ogy and alignment along the longitudinal 
axis of the ligament. Immunohistochemistry was not per- 
formed. 
The major parts Of the device 
TABLE 1 
Mechanical stresses applied to the ligaments in the bioreactors 
during Experiment 2. Note: cvcle 1 provided an initial 24 hr rest period. 
Duration Duration Time 
ToIFrom Extreme Home For One Total from 
Extreme Position Position Complete Cycle Start of 
Cycle AL, A b  Position Rest Rest Repetition Repetition Time Experiment 
# Degrees mm min hrs hrs hrs # Days Days 
1 0 0 0 
2 10 1 10 
3 15 1 15 
4 20 1 20 
5 25 1 25 
6 30 1 30 
7 35 1 30 
8 40 1 30 
9 45 1 30 
10 so 1 30 
11 55 1 30 
12 60 1 30 
13 65 1 30 
14 65 1 30 
15 65 1 30 
16 65 1 30 
17 65 1 30 
0 0 24 1 1  
0 0 0.33 36 0.5 
0 0 0.50 24 0.5 
0 0 0.67 18 0.5 
0 0 0.83 14 0.5 
0 0 1 12 0.5 
0 0 1 12 0.5 
0 0 1 12 0.5 
0 0 1 12 0.5 
0 0 1 12 0.5 
0 0 1 12 0.5 
1 0 2 24 2 
1 0 2 12 1 
1.5 0 2.5 10 1 
2 0 3 8 1  
2.5 0 3.5 7 1  
3 0 4 6 1  
1 
1.5 
2.0 
2.5 
3.0 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
8.0 
9.0 
10.0 
11.0 
12.0 
13.0 
loading regimes to the bioreactor tubes. FIG. 2 presents a 
schematic of the mechanical apparatus and FIG. 3 is a 
picture of the working device. 
Experiment 1 
The first experiment was performed to better characterize 
adhesion of the collagen matrix to the coral anchors. This 
experiment ran for a total of 12 days and encompassed 
rotational deformation of 10" initially, increasing to 65" by 
the end of the experiment. The linear deformation was 0.5 
mm along the longitudinal axis of the ligament for the 
majority of the 12 days. No loss of adhesion between the 
collagen matrix and the coral anchors was observed, indi- 
cating that at least a 65" rotational deformation could be 
tolerated by present system. 
Experiment 2 
The next set of experiments were conducted to study the 
effects of increased mechanical stresses on the growing 
ligaments. Linear deformation was kept constant at 1 mm 
(double that of Experiment 1) throughout the 13 day experi- 
ment while rotational deformation was increased progres- 
sively from 10" to 65" by the end of the experiment. The 
time to progress from one rotational extreme to the other 
extreme was maximally 30 minutes, with rests at the 
extreme points varying from 0 to 3 hours over the course of 
the experiment. Thus, complete cycles of mechanical defor- 
mation ranged from 0.33 hr to 4 hr. Adetailed description of 
the mechanical processes employed in this experiment is 
shown below to illustrate the range of control over the 
bioreactor that we can achieve with the apparatus (Table 1). 
FIG. 4 summarizes the rotational and translational strain 
rates used in this experiment. 
35 Experiment 3 
This set of studies was conducted to provide insight into 
the influence of frequency and cycling on ligament forma- 
tion in the bioreactors (FIGS. 5a&b). After a 48 hr rest 
period (represented as cycle l) ,  the rotational and translation 
strain rates and linear and rotational deformation were kept 
40 constant for 18.5 days. As illustrated in FIG. 5a, the liga- 
ments were exposed to a constant rotational and translational 
strain rate of 0.83% min-1 and 0.33% min-1, respectively, 
for 18.5 days. Rotational deformation (A degrees) and linear 
deformation (Amm) were kept constant at 90" and 2 mm 
45 respectively. FIG. 5b shows the deformation pattern. Slopes 
of the plotted lines indicate strain rate. 
Following the culture period, ligament samples, both the 
mechanically challenged as well as the controls (static) were 
characterized for: (1) general morphological appearance (by 
SO visual inspection); (2) cell distribution (image processing of 
histological sections); (3) cell orientation (histological 
analysis); and (4) tissue specific markers (immunostaining). 
Mechanical stimulation markedly affected the morphol- 
ogy of the engineered ACL, the distribution of cells along 
ss the matrix, and the extracellular matrix which was generated 
by the cells. 
The mechanical stimulation markedly affected the dimen- 
sions and overall appearance of the engineered ligaments. 
As compared to static controls, mechanically stimulated 
60 ligaments contracted laterally to a diameter of 5.1 mm after 
21 days in culture, as compared to 6.4 mm diameter for static 
controls (n=3 for each group) in Experiment 3. 
The mechanical stimulation also had a dramatic effect on 
cell density in the engineered ACL. Cells counts (N=8 fields, 
65 one ligament from each group,) were taken from cross 
sections of the control and mechanically challenged liga- 
ments from Preliminary Experiment 3 (FIG. 6). Cell density 
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of the ligament was approximately 3-fold higher in the 
center and -2-fold higher in the periphery in the mechani- 
cally deformed ligaments in comparison to the static con- 
trols. These data indicate that mechanical stimulation pro- 
vides suitable signals to the BMSCs to promote proliferation 
in the bioreactor environment. 
The mechanical stimulation also had a dramatic effect on 
cell orientation. Ligament tissue samples from Experiment 3 
were stained with hemotoxylin and eosin and visualized by 
light microscopy at 400x. Significant alignment in the 
BMSCs from the mechanically stimulated ligament was 
clearly seen, in comparison to the control (static) sample. 
Furthermore, this alignment had a lengthwise orientation 
along the longitudinal axis of the bioreactor tube, thus in the 
direction of the applied tension. The longitudinal orientation 
was similar to ligament fibroblasts found within an ACL in 
vivo (Woods et al. Amex J.  Sports Med. 19: 48-55 (1991)). 
The mechanical stimulation also had a dramatic effect on 
the development of tissue specific markers. Collagen I 
accounts for -88% of total collagen in the ACL. Collagen I11 
accounts for -12% of total collagen and fibronectin accounts 
for 2 pgimg dry tissue weight of an ACL (Amiel et al., 
Ligament structure, chemistry, and physiology. In Knee 
Ligaments: Structure, Function, Injury, and Repair. Eds. 
Daniel, D.; Akeson, W.; O'Connor. J. Raven Press (1990)). 
Collagen I, collagen I11 and fibronectin (as indicators of new 
ligament tissue formation and organization) were identified 
by immunostaining mechanically stimulated and control 
(static) ligament tissue samples from Experiment 3. 
Mechanically stimulated ligaments expressed ligament- 
specific molecular markers (collagen I11 and fibronectin), in 
contrast to static controls in which the expression was either 
low or not detectable. The diameter of the collagen I 
structures observed in the mechanically challenged liga- 
ments approached that of similar structures seen in naturally 
formed ACL collagen bundles, -20 pm. The morphology of 
these markers suggested the beginning of differentiation of 
BMSCs into ligament cells and similar structural features to 
an ACL in terms of fiber bundle orientation and diameter. 
The above results indicate that the mechanical apparatus 
and bioreactor system can provide a suitable environment 
for in vitro formation of tissue engineered ligaments starting 
from bone marrow stromal cells immobilized in a collagen 
gel matrix. 
The culture conditions used in these preliminary experi- 
ments can be further expanded to more accurately reflect the 
physiological environment of a ligament (e.g. increasing the 
different types of mechanical forces) for the in vitro creation 
of functional equivalents of native ACL for potential clinical 
use. These methods are not limited to the generation of a 
bioengineered ACL. Indeed, by applying the appropriate 
magnitude and variety of forces experienced in vivo, any 
type of ligament in the body can be produced ex vivo by the 
methods of the present invention. 
The above results gathered from these controlled in vitro 
studies of the roles of mechanical regulatory signals on 
precursor cell differentiation into ligament cells and in vitro 
development of an engineered ACL, further the understand- 
ing of the roles of mechanical regulatory signals in cell 
differentiation and tissue development. 
METHODS OF THE INVENTION 
Cell Isolation and Culture 
Bone Marrow Stromal Cells (BMSC), pluripotent cells 
capable of differentiating into osteogenic, chondrogenic, 
tendonogenic, adipogenic and myogenic lineages, were cho- 
sen since the formation of the appropriate conditions can 
direct their differentiation into the desired ligament fibro- 
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blast cell line (Markolf et al., J.  Bone Joint Surg. 7 1 A  
887-893 (1989); Caplan et al., Mesenchymal stem cells and 
tissue repair. In The Anterior Cruciate Ligament: Current 
and Future Concepts, Ed. D. W. Jackson et al., Raven Press, 
Ltd, New York (1993); Young et al.,J. Orthopaedic Res. 16: 
406-413 (1998)). Bone marrow cultures were established 
from the tibias and femurs of 2-3 week old bovine calves. 
The contents of the bone marrow cavity were aseptically 
harvested in a 50 ml centrifuge tube containing 15 ml 
phosphate buffered solution (PBS) with 0.05 mM ethylene 
diamine tetraacetic acid (EDTA). Single cell suspensions 
were made by repeatedly passing the marrow through 
needles of different gauges (16 to 20), and resuspended in 
Dulbecco's Modified Eagle Medium (DMEM) supple- 
mented with 10% fetal bovine serum (FBS), 0.1 mM non- 
essential amino acids (NEAA), 100 Uiml penicillin and 100 
mg/L streptomycin (PIS). White blood cells were counted 
using a hemocytometer, plated in 100 mm Petri dishes at 
2x106 cells per dish (approximately 25x10, cellsicm') in 10 
ml of medium supplemented with 1 ngiml fibroblast growth 
factor-2 (FGF-2) and cultured in a humidified 37" C./5% 
CO, incubator. 
BMSCs were selected pre-plating, based on their ability 
to adhere to the Petri dish; non-adherent hematopoietic cells 
were removed with the culture medium during medium 
replacement. The medium was changed twice per week. 
When BMSC became near confluent, after approximately 
2-3 weeks, upon which they were detached using 0.25% 
trypsinil mM EDTAand replated in 100 mm dishes at 3x10' 
cells per dish. After 1 more week, when dishes again became 
confluent, 1"' passage (Pl)  cells were trypsinized and 1 ml 
aliquots containing 2Ox1O6 cells (based on Goulet et al., 
1997) in lxDMEM were either seeded directly into the 
collagen gels or spun down and frozen in 8% DMSO 10% 
FBS lxDMEM solution for future use. 
The final medium in the 20 ml total volume of the reactor 
vessel consisted of  5.6 ml of 3.6xDMEM at pH 8.0,3.7 ml 
heat inactivated FBS (30 min at 56" C.), 9.5 ml of 4.22 
mgiml collagen [acid soluble collagen type I (Sigma type 
III)], 0.2 ml of 0.7 N NaOH and 1.0 ml of the cell 
preparation containing the 2Ox1O6 cells. The 3.6xDMEM 
consisted of 36 ml lOxDMEM containing 4500 mg glucose/ 
L, 0.4 mg powered folic acid, 2 ml of 200 mM L-glutamine, 
0.37 g sodium bicarbonate (NaHCO,), 200 Uiml penicillin, 
200 mg/L streptomycin, 0.5 pgiml Fungizone (PIS and 
Fungizone were purchased from Life Technologies) and 
ddH,O to bring the volume to 90 ml; the pH was adjusted 
to 8.0 with 2N NaOH, and enough ddH,O to bring the final 
volume to 100 ml. The 3.6xDMEM solution was well mixed 
and filtered through a 0.2 pm filter unit and stored at 4" C. 
Cell Immobilization in Collagen Matrix 
To prepare an individual bioreactor tube for a ligament 
growth experiment 2Ox1O6 P1 BMSCs were resuspended in 
1 ml IxDMEM, 9.5 ml of 4.22 mgiml bovine collagen type 
I, 5.6 ml3.6xDMEM, 3.7 ml heat inactivated FBS, and 0.2 
ml 0.7 N NaOH. The final concentration of collagen type I 
in solution was 2 mgiml. These reagents were first added to 
a 50 ml centrifuge tube on ice, then quickly transferred to the 
bioreactor tube. The bioreactor tube was fitted with a PTFE 
gas filter, loaded into the mechanical device, and placed in 
a humidified 37" C./5% CO, incubator. The collagen was 
allowed to gel for 24 hours. During a 24 or 48 hr initial 
growth period, the ligaments were not exposed to any 
mechanical stimulation except for gravity to allow for 
sufficient adhesion to develop between the collagen matrix 
and the coral anchors. Fifty percent of the medium was 
exchanged with 10% FBS in lxDMEM containing 200 Uiml 
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penicillin, 200 mg/L streptomycin, 0.5 pgiml Fungizone, rotational strain (up to 25% and 90 degrees), with a collagen 
after 24 hrs and two times a week thereafter. matrix which remained adherent to the coral anchors. 
Anchors for Ligament Matrix Bioreactor Operating Conditions 
Cylindrical pieces of Goinopra coral, 12 mm in diameter The coral anchors were fastened into the anchor mounts 
and 20 mm in length with a pore size of 500 pm (supplied s using the set screws. The upper and lower mounts, linear 
by Interpore-Cross International) were used as the anchors. bearings, rotational shaft, and silicone membrane are 
The coral was treated by a hydrothermal process to convert assembled with the teflon tube. Two caps were placed on the 
the  ca l c ium ca rbona te  to  ca l c ium phospha te  h e r  ports and the reactor tube is autoclaved for 20 minutes. 
(hydroxyapatite). This mineral content and pore size is All materials were selected to be stable in the autoclave. 
similar to some types of human cancellous bone and this i o  After autoclaving, the upper he r  cap is replaced with a 
material has been approved by the FDA for bone grafts. Gelman Acrodisc CR PTFE 1.0 pm filter for gas exchange. 
Bioreactor Design The matrix and tissue culture medium containing the cells 
The bioreactor tube design provided an environment for were injected through the lower port of the reactor tube 
the growth of a 4 cm long ligament when considering the using a 20 ml syringe. Following injection, the lower cap 
anchors, and approximately 2 cm long extending between is was replaced and the reactor tube inserted into the transla- 
the anchors. The terminology used in this document will be tional plate at a lowered position in the mechanical device. 
defined as follows: (a) translation load along the longitudinal The translational plate was then raised so that the end of the 
axis of the ligament-tension; (b) rotational load about the rotational shaft extending from the reactor tube inserted into 
longitudinal axis of the ligament-torsion; (c) change in a linear bearing press fit into the rotational plate and a pin 
length (ALJ along the longitudinal axis of the ligament- 20 hub spur gear (120 teeth, 1.666 inch pitch diameter, Nordex) 
linear deformation; (d) change in rotational degree (AL,) sitting above the plate. Once inserted into the gear, the 
about the longitudinal axis of the ligament-rotational rotational shaft was fastened with a set-screw. A second 
deformation; (e) strain (ALAoc, where L0,=20 mm initial stepper motor (400 stepsi360") coupled to a smaller pin hub 
length of ligament) along the longitudinal axis of the spur gear (30 teeth, 0.4166 inch pitch diameter) was used to 
ligament-translational strain; (0 strain (ALALor, where zs rotate the rotational shaft and hence the top coral anchor. 
L0,=3 60" initial non-strained position of ligament) about Since the two gears (motor gearhotation gear) are in a 4: l  
the longitudinal axis of the ligament-rotational strain; (g) ratio, tolerances precise to 0.225 degrees can be achieved 
strain rate (AL&,Jtime) along the longitudinal axis of the with this device. 
ligament-translational strain rate; (h) strain rate (ALJLJ Controls 
time) about the longitudinal axis of the ligament-rotational 30 In all experiments, control tubes consisted of identical 
strain rate; Note: strain is reported as a percentage of ALIL,. components and conditions (cells, media, matrix, anchors) 
The reactor tubes and the apparatus were placed in an to those described for the bioreactor tube experimental set 
incubator at 37" C. with 5% CO,. The reactor tubes are 2.54 up with the exception that these tubes were not mechanically 
cm in diameter and 10 cm long. The tubes were cut from deformed (static) in the apparatus. 
Teflon stock tubing (McMaster-Carr Supply Co.). Each 3s Software 
reactor tube was fitted with two nylon bulkhead-mounted Software used to control the mechanical device was 
hers  which serve as ports for medium and gas exchange. written using C programming language and Borland C++ 
The hers  were fit within tapped holes to avoid protrusion Compiler Version 5.0. The mechanical device was designed 
into the inner area of the tube. The anchor mounts were specifically for periodic torsional and tensile loads along the 
machined from Teflon rod stock and a 12 mm diameter by 40 longitudinal axis of the growing ligament. The software 
10 mm length hole was machined in the center of each provided precise independent control over the rotational and 
anchor mount to allow for co-axial alignment of the coral linear movement and the rates of these movements. Rates for 
anchors. The coral anchors were held in place with set- linear and rotational movement range from 1 mmiday and 
screws spaced 90" apart. The bottom section of the lower l'iday, respectively, to a maximum of 0.32 mmisec and 
anchor mount and the lower translational plate, respectively, 4s 45"isec. The software allowed the user to input the forward 
were machined with a square shape to prevent rotation of the and return rotational and linear rates, the duration to reach 
reactor tube with respect to the translational plate. The and return from the extreme points (e.g., maximum angle 
cylindrical section of the lower anchor mount is inserted into and distance), an intermediate period of rest or static mode 
the bottom of the teflon reactor tube and attached with a hose at the extreme point, a rest or static mode at the home point, 
clamp. A stepper motor (Servo Systems, 400 stepsi360") SO and the number of repetitions for the cycle. Several different 
coupled to a high precision lead screw (lead=0.635 cycles with varying loading regimes can be programmed and 
mmi360") and low drag torque anti-backlash nut mounted run for the duration of the experiment. 
into the translational plate provide translational tolerances Initial Experimental Runs 
precise to 1.6 pm. In preliminary studies, up to six reactor tubes have been 
The upper anchor mount was attached to a rotational shaft ss run concurrently for up to 21 days. A variety of loading 
with set screws. The shaft extended into the reactor tube regimes were studied to evaluate device performance, to 
through two teflon bearings. The lower of the two bearing determine ranges of conditions suitable for ligament 
was inserted into the top of the Teflon reactor tube and formation, and to define limits of mechanical stress which 
attached via a worm-drive clamp. The lower bearing did not can be applied while maintaining sufficient adhesion of the 
move while allowing for the free rotation of the shaft. Super 60 matrix to the anchors during ligament growth. 
stretch silicone rubber thick was used to extend between the Histology and Immunohistochemistry 
upper and lower teflon bearings in order to enclose the top Samples for histological analysis were fixed in neutral 
of the reactor tube and provide a barrier against contami- buffered formalin (4%) for 24 h at 4-8" C., embedded in 
nation. paraffin, and sectioned (5 pm thick) both along the longitu- 
The system used allowed for the application of a variety 65 dinal axis and in cross section through the center of the 
of loading regimes based on a combination of linear defor- ligament. Sections were stained with hematoxylin and eosin 
mation (up to 2 mm and a 10% translational strain) and (for cells) and trichrome (for cross-linked collagen). Poly- 
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clonal antibodies (for type I and I11 collagen) and mono- 
clonal antibodies (for elastin and fibronectin) were used to 
determine the presence and distribution of secreted matrix 
components by immunofluorescence. 
Cell Density, Distribution and Morphology 
Spatial distributions of cells within constructs were 
assessed by image analysis of the hematoxylin and eosin 
stained cross-sections. Black and white images were 
acquired using an inverted microscope (Nikon Diaphot), a 
video camera (Hitachi HV-C20), a frame grabber card 
(LG-3, Scion, Frederick, Md.), and NIH-Image version 1.61 
software. Fields measuring 0.30 mm2 were randomly chosen 
and classified as either central (C) or peripheral (P), depend- 
ing if the region was more or less than 0.63 mm from the 
outer surface of the ligament, respectively. In each field, the 
number of cells was determined by automated counting. For 
each tissue sample and time point, the average cell density 
was calculated from at least eight central or peripheral fields. 
Cell Specific Markers 
Immunofluorescence was used to determine BMSC dif- 
ferentiation into ligament cells, by assessing the production 
of specific proteins known to be necessary to maintain the 
overall integrity of an ACL: fibronectin, collagens I & 111. 
Monoclonal mouse anti-bovine elastin, goat serum, and 
anti-mouse IgG FITC conjugate developed in goat was 
obtained from Sigma. Polyclonal rabbit anti-bovine type I 
collagen and anti-bovine collagen type 111, and anti-rabbit 
IgG FITC developed in goat was obtained from Chemicon; 
polyclonal rabbit anti-human fibronectin was obtained from 
DAKO . 
What is claimed is: 
1. A method for producing an anterior cruciate ligament 
a) providing pluripotent cells, a 3-dimensional matrix of 
cylindrical form comprised of collagen, and two cylin- 
drically shaped anchors suitable for attachment to the 
matrix; 
b) seeding the cells in the matrix, either pre- or post- 
matrix formation, by means to uniformly immobilize 
the cells within the matrix; 
c) attaching a face of each respective anchor to either end 
of the seeded matrix so that the entire surface of each 
face of the seeded matrix of step b) contacts the face of 
the respective anchors; and 
d) culturing the cells in the anchored matrix of step c) 
under conditions appropriate for cell growth and 
regeneration, while subjecting the matrix to intermit- 
tent application of two or more mechanical forces via 
movement of one or both of the attached anchors, 
wherein one of the mechanical forces is tension. 
2. The method of claim 1 wherein the pluripotent cells are 
bone marrow stromal cells. 
3. The method of claim 1 wherein the seeded matrix has 
a concentration of collagen type I ranging from 2 mgiml to 
6 mgiml. 
4. The method of claim 3 wherein the seeded matrix has 
a final concentration of collagen type I of 2 mgiml. 
5. The method of claim 3 wherein the collagen is not cross 
linked. 
6. The method of claim 3 wherein the collagen is cross- 
linked. 
7. The method of claim 1 wherein the anchors are 
comprised of Goinopra coral with pore size 500 pm, the 
coral having been treated by means to convert the calcium 
carbonate to calcium phosphate. 
8. The method of claim 7 wherein the Goinopra coral is 
further infused with fibronectin. 
ex vivo, comprising the steps: 
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9. The method of claim 1 wherein the anchors are 
comprised of demineralized bone. 
10. The method of claim 9 wherein the bone is further 
infused with fibronectin. 
11. The method of claim 1 wherein the magnitude, dura- 
tion and combination of mechanical forces are changed over 
the period of culture to approach that which is experienced 
by a native ACL in vivo. 
12. The method of claim 1 wherein the mechanical forces 
mimic mechanical stimuli experienced by an anterior cru- 
ciate ligament in vivo. 
13. The method of claim 12 wherein the anchored matrix 
is further cultured under conditions which mimic the chemi- 
cal stimuli experienced by an anterior cruciate ligament in 
vivo. 
14. The method of claim 12 wherein the mechanical 
forces comprise tension and torsion. 
15. The method of claim 14 wherein the mechanical 
forces further comprise compression. 
16. The method of claim 14 wherein tension is applied at 
a translational strain rate of from 0.167% min-l to 0.33% 
min-l. 
17. The method of claim 16 further comprising transla- 
tional strain release at a rate of from 0.167% min-l to 0.33% 
min-l. 
18. The method of claim 14 wherein torsion is applied at 
a rotational strain rate of from 0.27% min-l to 0.83% min-l. 
19. The method of claim 18 further comprising rotational 
strain release at a rate of from 0.27% min-l to 0.83% min-l. 
20. The method of claim 14 wherein tension is applied to 
the ligament through a progressive linear deformation from 
0 to 10% of initial ligament length. 
21. The method of claim 14 wherein torsion is applied to 
the ligament through a progressive deformation of the 
ligament from 0 to 25% rotation. 
22. The method of claim 14 wherein the tension is applied 
with a cycling frequency of from 0.05 min-l to 0.00417 
min-l. 
23. The method of claim 14 wherein the torsion is applied 
with a cycling frequency of from 0.05 min-l to 0.00417 
min-l. 
24. The method of claim 14 wherein tension is applied to 
the ligament through a progressive linear deformation from 
0 to 10% of initial ligament length, at a rate of from 0.167% 
min-l to 0.33% min-l, followed by tension release at a rate 
of from 0.167% min-l to 0.33% min-l, with a cycling 
frequency of from 0.05 min-l to 0.00417 min-l. 
25. The method of claim 14 wherein torsion is applied to 
the ligament through a progressive deformation of the 
ligament from 0 to 25% rotation, at a rate of from 0.27% 
min-l to 0.83% min-l, followed by rotation release at a rate 
of from 0.27% min-l to 0.83% min-l, with a cycling 
frequency of from 0.05 min-l to 0.00417 min-l. 
26. The method of claim 14 wherein torsion is held at 
extreme points of rotational deformation for 0 to 3 hours/ 
cycle. 
27. The method of claim 14 wherein torsion is held at 
extreme points of translational deformation for 0 to 3 
hoursicycle. 
28. The method of claim 12 wherein a combination of 
mechanical forces are applied to simulate knee joint exten- 
sion. 
29. The method of claim 28 wherein the motion of knee 
joint extension is in the coronal plane. 
30. The method of claim 28 wherein the motion of knee 
joint extension is in the sagittal plane. 
31. The method of claim 12 wherein a combination of 
mechanical forces are applied to simulate knee joint flexion. 
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32. The methods of claim 12 wherein a combination of 
mechanical forces are applied which simulate a combination 
of flexion and extension, the combination of mechanical 
cruciate ligament which has helically organized fibers. 
by the method comprising the steps: 
43. The method of claim 42 wherein the pluripotent cells 
44. The method of claim 42 wherein the matrix has a 
are bone marrow stromal cells. 
forces being applied Over time to produce an anterior cylindrical form and is attached to the respective anchor 
s faces at each face of the cylinder. 
33, A bioengineered anterior cruciate ligament produced 45. The method of claim 42 wherein the matrix is com- 
prised of collagen. 
46. The method of claim 45 wherein the matrix has a a) providing pluripotent cells, a 3-dimensional matrix of concentration of collagen type I ranging from 2 mgiml to 6 
cylindrical form comprised of collagen, and two cylin- mgiml, 
drically shaped anchors suitable for attachment to the 10 47, The method of claim 46 wherein the collagen is not 
matrix; cross-linked. 
b) seeding the cells in the matrix, either pre- or post- 48. The method of claim 46 wherein the collagen is 
matrix formation, by means to uniformly immobilize cross-linked. 
the cells within the matrix; 49. The method of claim 42 wherein the anchors are 
.) attaching a face of each respective anchor to either end further infused with a factor which promotes matrix adhe- 
of the seeded matrix so that the entire surface of each sion to the anchor. 
face of the seeded matrix of step b) contacts the face of 42 wherein the anchors are 
the respective anchors; and comprised of Goinopra coral with pore size 500 pm, wherein 
the coral has been treated by means to convert the calcium 
50. The method Of 
d) culturing the cells in the anchored matrix of step c) 2o carbonate to calcium phosphate, 
under conditions appropriate for growth and 51, The method of claim 42 wherein the anchors are 
regeneration, while subjecting the matrix to intermit- comprised of demineralized bone, 
tent application of two or more mechanical forces via 52, The method of claim 42 wherein the ligament pro- 
movement of one or both of the attached anchors, duced is an anterior cruciate ligament, 
wherein one of the mechanical forces is tension. 53. The method of claim 42 wherein the magnitude, 
34. The bioengineered ligament of claim 33 wherein the duration and combination of mechanical forces are changed 
pluripotent cells are bone marrow stromal cells. over the period of culture to approach that which is expe- 
35. The bioengineered ligament of claim 34 which is rienced by a native ligament in vivo. 
characterized by cellular orientation and/or matrix crimp 54. The method of claim 42 wherein the anchored matrix 
pattern in the direction of the applied mechanical forces of 3o is further cultured under conditions which mimic the chemi- 
step d). 
36. The bioengineered ligament of claim 35 which is 55. The method of claim 42 wherein the mechanical 
further characterized by the production of collagen type I, 
collagen type 111, and fibronectin proteins along the axis of 56. The method of claim 55 wherein the mechanical 
mechanical load produced by the mechanical forces of step 35 forces further comprise compression. 
4 .  57. The method of claim 42 wherein a combination of 
37. The bioengineered ligament of claim 34 wherein the mechanical forces are applied to simulate extension of the 
mechanical forces of step d) mimic mechanical stimuli joint in which the ligament is located in vivo. 
experienced by an anterior cruciate ligament in vivo. 58. The method of claim 42 wherein a combination of 
38. The bioengineered ligament of claim 37 wherein the 4o mechanical forces are applied to simulate flexion of the joint 
ligament fiber bundles are arranged into a helical organiza- in which the ligament is located in vivo. 
tion. 59. The methods of claim 42 wherein a combination of 
39. The bioengineered ligament of claim 37 wherein the mechanical forces are applied which simulate a combination 
mechanical forces comprise tension and torsion. of flexion and extension, the combination of forces being 
40. The bioengineered ligament of claim 39 wherein the 45 applied over time to produce a ligament which has helically 
mechanical forces comprise tension and torsion. organized fibers. 
41. The bioengineered ligament of claim 40 wherein the 60. A bioengineered ligament or tendon produced by the 
mechanical forces further comprise compression. method comprising the steps: 
42. A method for producing a predetermined type of a) providing pluripotent cells, a 3-dimensional matrix to 
ligament or tendon ex vivo, comprising the steps: which cells are able to adhere, and two anchors each 
a) providing pluripotent cells, a 3-dimensional matrix to having a face which is suitable for attachment to the 
which cells are able to adhere, and two anchors each matrix; 
having a face which is suitable for attachment to the b) seeding the cells in the matrix, either pre- or post- 
matrix; matrix formation, by means to uniformly immobilize 
b) seeding the cells in the matrix, either pre- or post- 55 the cells within the matrix; 
matrix formation, by means to uniformly immobilize c) attaching the face of the respective anchors to opposite 
the cells within the matrix; ends of the seeded matrix; and 
C) attaching the face of each respective anchor to opposite d) culturing the cells in the anchored matrix of step c) 
ends of the seeded matrix; and under conditions appropriate for cell growth and 
d) culturing the cells in the anchored matrix of step c) 60 regeneration, while subjecting the matrix to intermit- 
under conditions appropriate for cell growth and tent application of two or more mechanical forces via 
regeneration, while subjecting the matrix to intermit- movement of one or both of the attached anchors, 
tent application of two or more mechanical forces via wherein one of the mechanical forces is tension and the 
movement of one or both of the attached anchors, mechanical forces mimic forces experienced by the 
wherein one of the mechanical forces is tension, and the 65 ligament in vivo. 
mechanical forces mimic mechanical forces experi- 61. The bioengineered ligament or tendon of claim 60 
enced by the ligament in vivo. wherein the pluripotent cells are bone marrow stromal cells. 
25 
cal stimuli experienced by a native ligament in vivo. 
forces comprise torsion and tension. 
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62. The bioengineered ligament or tendon of claim 61 
which is characterized by cellular orientation in the direction 
of the applied mechanical forces of step d). 
63. The bioengineered ligament or tendon of claim 62 
which is further characterized by collagen I11 fiber produc- 
tion and fibronectin fiber production along the axis of 
mechanical load produced by the mechanical forces of step 
64. The bioengineered ligament or tendon of claim 60 
wherein the mechanical forces of step d) mimic mechanical 
stimuli experienced by the ligament or tendon in vivo. 
65. The bioengineered ligament or tendon of claim 64 
wherein the ligament fiber bundles are arranged into an 
helical organization. 
66. The bioengineered ligament of claim 64 wherein the 
mechanical forces comprise tension and torsion. 
67. The bioengineered ligament of claim 66 wherein the 
mechanical forces comprise tension and torsion. 
68. The bioengineered ligament of claim 66 wherein the 
mechanical forces further comprise compression. 
69. A method for producing an anterior cruciate ligament 
ex vivo, comprising the steps: 
a) providing pluripotent cells, a 3-dimensional matrix of 
cylindrical form comprised of collagen, and two cylin- 
drically shaped anchors suitable for attachment to the 
matrix; 
b) seeding the cells in the matrix, either pre- or post- 
matrix formation, by means to uniformly immobilize 
the cells within the matrix; 
c) attaching a face of each respective anchor to either end 
of the seeded matrix so that the entire surface of each 
face of the seeded matrix of step b) contacts the face of 
the respective anchors; and 
d) culturing the cells in the anchored matrix of step c) 
under conditions appropriate for cell growth and 
regeneration, while subjecting the matrix to intermit- 
tent application of one or more mechanical forces via 
movement of one or both of the attached anchors, 
wherein one of the mechanical forces is torsion. 
70. A bioengineered anterior cruciate ligament produced 
a) providing pluripotent cells, a 3-dimensional matrix of 
cylindrical form comprised of collagen, and two cylin- 
drically shaped anchors suitable for attachment to the 
matrix; 
b) seeding the cells in the matrix, either pre- or post- 
matrix formation, by means to uniformly immobilize 
the cells within the matrix; 
c) attaching a face of each respective anchor to either end 
of the seeded matrix so that the entire surface of each 
4 .  
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face of the seeded matrix of step b) contacts the face of 
the respective anchors; and 
d) culturing the cells in the anchored matrix of step c) 
under conditions appropriate for cell growth and 
regeneration, while subjecting the matrix to intermit- 
tent application of one or more mechanical forces via 
movement of one or both of the attached anchors, 
wherein one of the mechanical forces is torsion. 
71. A method for producing a predetermined type of 
a) providing pluripotent cells, a 3-dimensional matrix to 
which cells are able to adhere, and two anchors each 
having a face which is suitable for attachment to the 
b) seeding the cells in the matrix, either pre- or post- 
matrix formation, by means to uniformly immobilize 
the cells within the matrix; 
c) attaching the face of each respective anchor to opposite 
ends of the seeded matrix; and 
d) culturing the cells in the anchored matrix of step c) 
under conditions appropriate for cell growth and 
regeneration, while subjecting the matrix to intermit- 
tent application of one or more mechanical forces via 
movement of one or both of the attached anchors, 
wherein one of the mechanical forces is torsion, and the 
mechanical forces mimic mechanical forces experi- 
enced by the ligament in vivo. 
72. A bioengineered ligament or tendon produced by the 
a) providing pluripotent cells, a 3-dimensional matrix to 
which cells are able to adhere, and two anchors each 
having a face which is suitable for attachment to the 
matrix; 
b) seeding the cells in the matrix, either pre- or post- 
matrix formation, by means to uniformly immobilize 
the cells within the matrix; 
c) attaching the face of the respective anchors to opposite 
ends of the seeded matrix; and 
d) culturing the cells in the anchored matrix of step c) 
under conditions appropriate for cell growth and 
regeneration, while subjecting the matrix to intermit- 
tent application of one or more mechanical forces via 
movement of one or both of the attached anchors, 
wherein one of the mechanical forces is torsion and the 
mechanical forces mimic forces experienced by the 
ligament in vivo. 
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